Blog

Ideas for pharma marketing teams building with AI.

Notes on grounded content, MLR-native workflows, and what actually changes once AI is writing the first draft.

Try
Featured

Compliance12 min read

How to run doctor consent-based video campaigns that actually convert

Consent is not just a legal checkbox. For pharma teams, it is the difference between cold distribution and a trusted HCP content channel that compounds over time.

SwishX Team · Jul 31, 2026Read article

Latest

View all

Explore by topic

Start with the questions your team is asking.

All articles

Everything we have published, newest first.

Compliance9 min read

FDA's DTC crackdown and the end of adequate provision: what pharma marketers should do now

FDA sent a wave of enforcement letters over DTC advertising in September 2025 and has put a rule to remove adequate provision on its agenda. What has changed, what has not, and how to prepare broadcast, digital and social content in 2026.

Oct 30, 2026

Compliance7 min read

The MLR review process in pharma: steps, roles and how to make it faster

MLR review is where most pharma content timelines are won or lost. How the process works step by step, what each reviewer is checking, why assets come back, and the changes that shorten review without lowering the bar.

Oct 27, 2026

Compliance7 min read

Fair balance in pharma promotion: what FDA expects, and a checklist to get it right

Fair balance is the requirement that risk gets comparable prominence to benefit, and the most common reason FDA objects to promotional content. How it is judged, where content usually fails, and a channel-by-channel checklist.

Oct 23, 2026

Platform6 min read

Modular content in pharma: how to build a claims library your MLR team trusts

Modular content promises faster review and more reuse, but most programs stall because the claims underneath are not structured for it. What a usable claims library looks like, record by record, and how to run it day to day.

Oct 20, 2026

Magic Studio

Want to see Magic Studio on your brand?

Video, docs, ads, approved email and web, made from your approved claims and ready for MLR review.

Book a demo

AI Strategy7 min read

Common HCP objections in pharma sales, and how to answer each one on label

Physicians raise the same handful of objections again and again. The ones that matter most, why each comes up, a compliant way to respond, and the lines a rep must not cross while doing it.

Oct 16, 2026

AI Strategy10 min read

A 95% quiz score doesn't mean your rep is ready for the room

Certification tests what a rep can recall alone, at their own pace. The room tests what they can say out loud, on label, the moment a skeptical physician pushes back. Those are not the same skill.

Oct 1, 2026

Platform11 min read

The objection response decides the account, not the pitch

Most pharma sales training spends its time on the pitch and almost none on the comeback, yet the comeback is where the account is actually won or lost. Here is what a strong objection response looks like, and why practicing it requires an unpredictable partner, not a script.

Oct 1, 2026

AI Strategy10 min read

A company-wide leaderboard is the worst way to motivate a pharma sales team

Most sales gamification rewards a flat activity count and ranks reps against markets they do not share. The lever pharma sales leaders are actually missing is a visible link between a Tuesday roleplay session and the outcome it is supposed to produce.

Oct 1, 2026

See it run on your own brand.

Book a 30-minute demo and watch a brief become a review-ready asset before the call ends. Or start free and make one yourself.

Selected for the AWS & Anthropic Agentic AI Accelerator as the only life sciences company in the 2026 cohort